







The compliance spiral in pharma manufacturing
Indian pharma plants face six-month incident backlogs and delayed batch releases. Discover how redesigning work could help India credibly reach its $130 billion pharma ambition by 2030.
Read MoreImplementation focussed and a “skin-in-the-game” pricing model
Read MoreListen to breakthrough solutions for wicked problems in business
Read MoreDelivering industry defying results
The compliance spiral in pharma manufacturing
Indian pharma plants face six-month incident backlogs and delayed batch releases. Discover how redesigning work could help India credibly reach its $130 billion pharma ambition by 2030.
Read More